Published on Sep 1, 2014

*NOTE*TUMOR DOCUMENTED FROM ONLY A 5 WEEKS TIME PERIOD-DID NOT LET GROW, WAS NOT A LONG TIME AS THIS HAPPENED FAST, WAS UNDER DR CARE ENTIRE TIME, SCC DID NOT FROM SUN EXPOSURE AND LACK OF SUN SCREEN BUT A GENETIC TRIGGER AND VIRUS.******TUMOR GREW IN ONLY 5 WEEKS TIME-EXTREMELY FAST AND AGGRESSIVE!

Published on Jun 8, 2015

Merkel Cell is an aggressive kind of skin cancer that has tripled in volume over the past several years. Want to know how you can protect your skin especially during these hot summer months? Radiation Oncologist Dr. Christopher Balamucki gives advice on how to keep your skin healthy, how to prevent skin cancer and what to look for if you're concerned.

Published on Jun 6, 2016

Dr. Paul Nghiem discusses his research at the ASCO 2016 meeting in Chicago.

Published Aug 2, 2016

Dr Kaufman speaks with ecancertv at ASCO 2016 to discuss the results of phase II JAVELIN Merkel 200 trial, in which patients with metastatic Merkl cell carcinoma received avelumab, a PD-L1 checkpoint inhibitor.

Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with Merkel cell polyomavirus, with limited therapeutic options after 1st-line chemotherapy.

Dr Kaufman describes the results of the JAVELIN trial in which, of a cohort of 88, six patients (9.8%) achieved complete responses, 12 (19.7%) had partial responses, and 7 (11.5%) had stable disease (83.3% responses were ongoing).

He also details the ongoing progression free survival data, and offers that additional clinical evaluation of avelumab for is warranted.

Published on May 1, 2015

Symptoms, risk factors and treatments of Primary central nervous system lymphoma (Medical Condition)

A primary central nervous system lymphoma, also known as microglioma and primary brain lymphoma, is a primary intracranial tumor appearing mostly in patients with severe immunosuppression

This video contains general medical information If in doubt, always seek professional medical advice.
The medical information is not advice and should not be treated as such. The medical information is provided without any representations or warranties, express or implied. We do not warrant or represent that the medical information on this websiteis true, accurate, complete, current or non-misleading

Music: 'Undaunted' Kevin Macleod CC-BY-3.0
Source/Images: "Primary central nervous system lymphoma" CC-BY-2.5 https://www.freebase.com/m/0dw1wf

Published on Feb 10, 2016

Immune suppression (HIVE/AIDS, organ transplantation, etc). is a known risk-factor for Primary CNS Lymphoma (PCNSL). When lymphoma occurs in the CNS, 80% are primary in the brain (not elsewhere) and usually intraaxial (often deep around the ventricles).

Published on Aug 31, 2016

Phillip Martin Pierorazio, M.D. is an expert in treating urinary-tract malignancies—including kidney, bladder, prostate, testis, adrenal, penile and urethral cancers. He performs both open and minimally invasive surgeries. These include laparoscopic and robotic surgeries of the kidney, bladder, prostate, and retroperitoneal lymph node dissection for testicular cancer. He has a special interest in kidney cancer and performs such specialized procedures as partial nephrectomy for early-stage disease and high-risk surgeries for advanced urological cancers. He is the Director of the Division of Testicular Cancer and works with a number of testicular cancer advocacy groups around the country. Learn more about Dr. Pierorazio at: http://www.hopkinsmedicine.org/profiles/results/directory/profile/523073...

Published on Jul 31, 2015

Learn more about radiation therapy treatment from a patient's perspective. Find out how long appointments last, what to expect during the treatment, and also what the side effects may be from treatment.

Published on May 16, 2016

Eric was diagnosed with Stage IV cancer and was treated at UPMC CancerCenter. He has now been cancer-free for a year.

Discover more stories like Eric's at upmcstories.com.

Published on Sep 2, 2016

Wisconsin and Michigan have challenged each other to see which can raise the most money for pediatric cancer research during September. Will you help us beat C.S. Mott Children's Hospital​ and our common enemy - childhood cancer? Give now: http://uwhealth.org/fightkidscancer #UWKidsCancer